EI
PCRX icon

Ellevest Inc’s Pacira BioSciences PCRX Stock Holding History

Ellevest Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-457
Closed -$18.6K – 1257
2023
Q1 		$18.6K Buy
+457
New +$18.2K ﹤0.01% 858
2021
Q2 		– Sell
-176
Closed -$12K – 1374
2021
Q1 		$12K Hold
176
– – ﹤0.01% 758
2020
Q4 		$11K Sell
176
-11
-6% -$644 ﹤0.01% 733
2020
Q3 		$11K Hold
187
– – ﹤0.01% 636
2020
Q2 		$10K Hold
187
– – ﹤0.01% 626
2020
Q1 		$6K Hold
187
– – ﹤0.01% 627
2019
Q4 		$8K Buy
+187
New +$7.94K ﹤0.01% 554

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ellevest Inc's PCRX Position: Q2 2023 in Review

Ellevest Inc sold out of Pacira BioSciences (PCRX) in Q2 2023, closing a stake of 457 shares — an estimated $18.6K sold.

Ellevest Inc first reported a position in PCRX in Q4 2019 and held it in 7 quarters. The position peaked at $18.6K in Q1 2023. 258 funds tracked by Wall St. Rank hold PCRX as of Q2 2023.

  • Ellevest Inc reported no remaining Pacira BioSciences position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 457 Pacira BioSciences shares in Q2 2023, an estimated $18.6K.
  • Ellevest Inc first reported a position in Pacira BioSciences in Q4 2019 and held it in 7 quarters.
  • Ellevest Inc's Pacira BioSciences position peaked at $18.6K in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.